(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PLACENTX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PLACENTX

ST13

US500000088889237

Class

1, 5

Filing

88889237

Registration

6503325

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

09/28/2021

Trademark type

Combined

Nice classes

1, 5

Filing date

04/27/2020

Registration date

09/28/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/28/2021

Last transaction

09/28/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/01/2021

First use in commerce

01/01/2021

Drawing code

3

Owner type

16

Owner location

Willowbrook, IL, US

Examiner

ENGEL, MICHAEL

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the literal element "placenTX" in stylized font with a first band extending below the literal element from the letter "p" to the letter "t", and a second band extending above the literal element from the letter "x" to the letter "a" and forming part of the letter "x".

Holders and representatives

Holders

BioSTAR Medical, LLC

Representatives

Ryan D. Artis RIVERSIDE LAW LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biological tissuehuman tissue for use in scientific and medical research

Class 5

Biological tissueliquid placental connective tissue for wound care and treating inflammatory conditions; Human allograft tissue; Biological tissue grafts; Biological human tissue intended for subsequent implantation; Biological implantsa vital processed human or animal connective tissue

Publications

History of USPTO decisions and trademark events.

26 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

09/28/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/26/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/25/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/25/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/24/2021

IUAF

USE AMENDMENT FILED

08/20/2021

EISU

TEAS STATEMENT OF USE RECEIVED

08/20/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/20/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/23/2021

PUBO

PUBLISHED FOR OPPOSITION

02/23/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/03/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/19/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/19/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/19/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/28/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/24/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/24/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/24/2020

CEPE

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED

07/22/2020

ALIE

ASSIGNED TO LIE

07/21/2020

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

07/21/2020

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

07/21/2020

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

07/21/2020

DOCK

ASSIGNED TO EXAMINER

07/21/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/15/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/14/2020

Continuous trademark protection

Get notified about every new filing that threatens PLACENTX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.